Our skilled team, under the Lung Institute at Banner – University Medical Center Phoenix’s campus recognize that contributing factors to the development of pulmonary fibrosis can include inflammatory diseases such as sarcoidosis and infection, and exposure to asbestos or gasses can also contribute to the likelihood of being diagnosed with pulmonary fibrosis.
In addition, those with autoimmune disorders such as rheumatoid arthritis, lupus, and scleroderma are also more prone to the development of pulmonary fibrosis.
Some of the services offered at the Interstitial Lung Disease Center include:
- Collaboration with our thoracic surgeons for biopsy procedures
- Access to treatment from our highly skilled thoracic radiology team
- Pulmonologists with expertise in the treatment of interstitial lung diseases
- Pulmonary Fibrosis support group information and resources
- Comprehensive lab testing to rule out contributing illnesses such as lupus, scleroderma, sarcoidosis, or rheumatoid arthritis
- Rajeev Saggar, MD – Center Director – Interstitial Lung Disease Center
Patients are provided educational materials, including individualized treatment plans and outlining expectations for their care. Family education and support is always available for specific questions or follow up concerns.
The University of Arizona, in coordination with Banner – University Medicine, conducts a variety of research studies and clinical trials to support a commitment to improving patient care. As a patient at Banner – University Medical Center, you may be eligible to participate, meaning you’ll have access to new treatments, which may not yet be available to the public.
Our team is committed to providing each patient with helpful resources to improve their health and well-being.